uniQure (QURE) Total Liabilities (2015 - 2026)
uniQure (QURE) recorded quarterly Total Liabilities of $629.4 million in Q1 2026, up 0.54% quarter-over-quarter from $626.0 million in Q4 2025, and up 10.08% on a YoY basis from $571.7 million in Q1 2025.
uniQure (QURE) Total Liabilities (2015 - 2026) Analysis & Trends
uniQure's Total Liabilities history runs 12 years deep, the most recent figure standing at $629.4 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 10.08% year-over-year to $629.4 million; the TTM figure through Mar 2026 stood at $629.4 million (up 10.08% YoY), while the FY2025 annual figure was $626.0 million, up 11.13% from the prior year.
- Total Liabilities was $629.4 million for Q1 2026 at uniQure, up from $626.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $659.6 million in Q3 2025 to a low of $211.1 million in Q1 2022.
- Historically, Total Liabilities has averaged $493.7 million across 5 years, with a median of $589.4 million in 2023.
- Biggest YoY gain for Total Liabilities was 185.61% in 2024; the steepest drop was 9.73% in 2024.
- A 5-year view of Total Liabilities shows it stood at $229.0 million in 2022, then surged by 172.55% to $624.0 million in 2023, then decreased by 9.73% to $563.3 million in 2024, then climbed by 11.13% to $626.0 million in 2025, then climbed by 0.54% to $629.4 million in 2026.
- The last three Total Liabilities figures came in at $629.4 million (Q1 2026), $626.0 million (Q4 2025), and $659.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 629.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 629.36 Mn |
| Dec 31, 2025 | 626.01 Mn |
| Sep 30, 2025 | 659.64 Mn |
| Jun 30, 2025 | 588.89 Mn |
| Mar 31, 2025 | 571.72 Mn |
| Dec 31, 2024 | 563.29 Mn |
| Sep 30, 2024 | 589.99 Mn |
| Jun 30, 2024 | 633.74 Mn |
| Mar 31, 2024 | 623.30 Mn |
| Dec 31, 2023 | 624.02 Mn |
| Sep 30, 2023 | 602.77 Mn |
| Jun 30, 2023 | 589.45 Mn |
| Mar 31, 2023 | 218.23 Mn |
| Dec 31, 2022 | 228.96 Mn |
| Sep 30, 2022 | 217.06 Mn |
| Jun 30, 2022 | 214.72 Mn |
| Mar 31, 2022 | 211.15 Mn |
| Dec 31, 2021 | 213.40 Mn |
| Sep 30, 2021 | 183.87 Mn |
| Jun 30, 2021 | 150.66 Mn |